Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Squamous Cell
  • Chemoradiotherapy
  • Head and Neck Neoplasms
  • Hypopharyngeal Neoplasms
  • Laryngeal Neoplasms
  • Oropharyngeal Neoplasms

abstract

  • Concomitant chemoradiation is associated with improved survival for patients with T1-2N1 HNSCC. Prospective trials in this population should be pursued. Cancer 2017;123:1555-1565. © 2017 American Cancer Society.

publication date

  • May 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.30508

PubMed ID

  • 28001302

Additional Document Info

start page

  • 1555

end page

  • 1565

volume

  • 123

number

  • 9